CING Insider Trading

Insider Ownership Percentage: 31.28%
Insider Buying (Last 12 Months): $228,178.70
Insider Selling (Last 12 Months): $22,265.64

Cingulate Insider Trading History Chart

This chart shows the insider buying and selling history at Cingulate by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cingulate Share Price & Price History

Current Price: $0.98
Price Change: Price Decrease of -0.0219 (-2.19%)
As of 09/26/2022 01:18 PM ET

This chart shows the closing price history over time for CING up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cingulate Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/8/2022Jennifer L CallahanInsiderBuy3,500$1.50$5,250.0021,943View SEC Filing Icon  
9/6/2022Peter J WerthDirectorBuy74,500$1.52$113,240.00946,231View SEC Filing Icon  
6/1/2022Laurie MyersCOOBuy200$1.18$236.0046,716View SEC Filing Icon  
5/17/2022Laurie MyersCOOBuy200$1.21$242.0046,516View SEC Filing Icon  
5/6/2022Curtis MedeirosDirectorSell17,532$1.27$22,265.64View SEC Filing Icon  
3/17/2022Peter J WerthDirectorBuy27,000$1.79$48,330.00View SEC Filing Icon  
3/16/2022Jennifer L CallahanInsiderBuy1,900$1.39$2,641.00View SEC Filing Icon  
3/16/2022Laurie MyersCOOBuy353$1.40$494.20View SEC Filing Icon  
3/14/2022Craig S GilgallonEVPBuy5,975$1.38$8,245.50View SEC Filing Icon  
3/14/2022Gregg Wm GivensDirectorBuy9,000$1.32$11,880.00View SEC Filing Icon  
3/14/2022Horn Louis G VanCFOBuy15,000$1.34$20,100.00View SEC Filing Icon  
3/14/2022Jennifer L CallahanInsiderBuy12,000$1.46$17,520.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cingulate (NASDAQ:CING)

5.72% of Cingulate stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CING by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cingulate Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/16/2022Creative Planning23,510$34K0.0%N/A0.208%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC44,600$65K0.0%-12.5%0.394%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC51,000$100K0.0%N/A0.451%Search for SEC Filing on Google Icon
5/12/2022Eagle Asset Management Inc.47,895$94K0.0%N/A0.424%Search for SEC Filing on Google Icon
5/5/2022Lynwood Capital Management Inc.225,994$0.45M0.5%+80.8%1.998%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP83,931$0.23M0.1%N/A0.742%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cingulate logo
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
Read More on Cingulate

Today's Range

Now: $0.98
Low: $0.98
High: $1.00

50 Day Range

MA: $1.46
Low: $1.00
High: $1.83

52 Week Range

Now: $0.98
Low: $0.97
High: $5.15


286 shs

Average Volume

154,777 shs

Market Capitalization

$11.06 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Cingulate?

Cingulate's top insider investors include:
  1. Peter J Werth (Director)
  2. Laurie Myers (COO)
  3. Jennifer L Callahan (Insider)
  4. Craig S Gilgallon (EVP)
  5. Curtis Medeiros (Director)
  6. Gregg Wm Givens (Director)
  7. Horn Louis G Van (CFO)
Learn More about top insider investors at Cingulate.

Who are the major institutional investors of Cingulate?

Cingulate's top institutional investors include:
  1. Renaissance Technologies LLC — 0.39%
  2. Creative Planning — 0.21%
Learn More about top institutional investors of Cingulate stock.

Which major investors are selling Cingulate stock?

During the last quarter, CING stock was sold by these institutional investors:
  1. Renaissance Technologies LLC

Which major investors are buying Cingulate stock?

During the previous quarter, CING stock was bought by institutional investors including:
  1. Creative Planning
In the previous year, these company insiders have bought Cingulate stock:
  1. Peter J Werth (Director)
  2. Laurie Myers (COO)
  3. Jennifer L Callahan (Insider)
  4. Craig S Gilgallon (EVP)
  5. Curtis Medeiros (Director)
  6. Gregg Wm Givens (Director)
Learn More investors buying Cingulate stock.